Navigation Links
40 86 Strategic Income Fund Declares Dividend
Date:10/17/2007

CARMEL, Ind., Oct. 17 /PRNewswire-FirstCall/ -- 40|86 Strategic Income Fund (NYSE: CFD) declared a dividend of $0.06250 per share, payable November 9, 2007 to holders of record at the close of business on October 31, 2007.

40|86 Strategic Income Fund is a closed-end investment management company. The Fund's primary investment objective is to seek high current income. As discussed in the Fund's prospectus, the Fund intends to distribute substantially all of its net investment income monthly. All net realized capital gains, if any, generally will be distributed to the Fund's shareholders at least annually, although net capital gains (i.e., the excess of net long-term capital gains over net short-term capital losses) may be retained by the Fund.

The Fund is managed by 40|86 Advisors, Inc., a wholly owned subsidiary of Conseco, Inc. (NYSE: CNO). Conseco, Inc.'s insurance companies help protect working American families and seniors from financial adversity: Medicare supplement, long-term care, cancer, heart/stroke and accident policies protect people against major unplanned expenses; annuities and life insurance products help people plan for their financial futures.


'/>"/>
SOURCE 40|86 Strategic Income Fund
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Pharma cos must forge Strategic alliances
2. Zydus Cadila and Kopran in strategic alliance
3. A strategic study: Soy diet makes heart disease to worsen in male mice
4. Researchers Make a Major Strategic Breakthrough in Controlling the AIDS Virus
5. NHS Makes A Strategic Move For The Dentists From Leaving Its Services
6. Thailand Approves Strategic Plan To Reduce HIV Prevalence Among Youth
7. Shorter infants have lower incomes in later life
8. Research shows that death may occur differently depending on the income level
9. Education And Income Level May Not Guarantee Health
10. The trident of unhealthy teen choices is early Lunch, Soft Drink Machine Income and Parents who relent
11. Health Insurance for Low-Income Expats in UAE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... With ... pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation Center is ... of successfully certified products, services and staff. , Validation Center is ISO17025 accredited ...
(Date:5/26/2016)... Louis, Missouri (PRWEB) , ... May 26, 2016 ... ... cost, quality and clinical outcomes, hosted members and suppliers for its inaugural Member ... a focus on their mission of elevating the operational health of America’s healthcare ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... that has a significant negative impact on long-term patient survival, reports a team ... results, published online this week in the Journal of Thoracic and Cardiovascular Surgery, ...
(Date:5/26/2016)... ... , ... An April Gallup survey found rising health care costs to be ... Health Senior Living (SHSL) may not share those same worries thanks to a ... the year, while holding the line on increasing their contributions, including premiums, deductibles and ...
(Date:5/26/2016)... , ... May 26, 2016 , ... The Lung ... host a six-week smoking cessation class starting June 6 at their clinic in downtown ... http://www.gnahec.org . , Additionally, the Lung Institute has created a free downloadable 4 Week ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25, 2016 ... 2016"market research report that provides an overview on ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ... reviews key players involved in the therapeutic development ...
(Date:5/24/2016)...   , Study met both ... superiority in , Excellent plus Good ... of the ascending colon   , ... today announced new positive data from the phase III MORA study ... 2 litre PEG with ascorbate. The study met both primary endpoints ...
(Date:5/24/2016)... , May 24, 2016 Celsion Corporation ... development company, today provided an update on its ... clinical trial combining GEN-1, the Company,s DNA-based immunotherapy, ... of newly-diagnosed patients with advanced ovarian cancer who ... surgery.  GEN-1 is an IL-12 DNA plasmid vector ...
Breaking Medicine Technology: